Friday, June 19, 2026

What to Expect from Kim Min-seok’s 75-Minute Press Conference: Trade, Politics, and More

Prime Minister Kim Min-seok's upcoming press conference will address U.S. visit outcomes, tariffs, and his political ambitions for leadership.

Strengthening the Korea-U.S. Alliance: Key Takeaways from Jang Dong-hyuk’s Washington DC Meetings

Jang Dong-hyuk of the People Power Party discusses U.S.-South Korea relations and security strategies during his D.C. visit.

2026 Global Auto Market Forecast: Will China and U.S. Sales Decline Impact Your EV Choices?

Global automotive sales are set to stabilize with modest growth, impacted by market slowdowns in China and the U.S.

Tag: pharmaceutical

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Eli Lilly vs. Novo Nordisk: A $1.2 Billion Bet Reveals Two Very Different Futures for Obesity Drugs

Eli Lilly and Novo Nordisk are pursuing different strategies in the obesity treatment market, focusing on expansion versus core strengths.

2025’s Drug Price Revolution: What Asian Pharma Firms Need to Know About MFN Policies

Trump's second term sees U.S. drug pricing reforms and supply chain shifts, prompting South Korean firms to seize new opportunities.

JW Pharmaceutical Secures U.S. Patent for Hair Loss Drug Candidate JW0061

JW Pharmaceutical secures a U.S. patent for hair loss treatment JW0061, targeting GFRA1 receptor, ensuring market exclusivity until 2039.

Unlocking Convenience: Rolvedon’s Same-Day Chemotherapy Solution for Neutropenia Revealed

Hanmi Pharmaceutical's Rolvedon shows potential for same-day chemotherapy administration, improving patient convenience and market competitiveness.

Chinese & Indian Medical Invasion: Pharmaceutic Dependency on Risk of Essential Medicine Supply

Concerns rise over South Korea's API industry reliance on China and India, with self-sufficiency at a record low of 25.6% in 2023.

From R&D to Global Blockbuster: Fexuclue Sparks a New Vision for Daewoong

Daewoong Pharmaceutical's Fexuclue achieves rapid success with innovative marketing and aims for significant growth in treating GERD.

New Obesity Pill Could End Wegovy’s Reign, Offering Faster and Safer Results

Ildong's ID110521156 shows promise as an affordable GLP-1 obesity drug with fewer side effects, aiming to transform the treatment landscape.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.